检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张蓓蓓[1] ZHANG Bei-bei(China Chamber of Commerce for Import & Export of Medicines & Health Products, Beijing 100010, Chin)
出 处:《精细与专用化学品》2018年第3期1-3,共3页Fine and Specialty Chemicals
摘 要:2017年,随着新一轮更加激烈的国际产业竞争,我国医药贸易遭遇的贸易摩擦数量明显上升,达到15起。新兴医药市场对我国发起调查呈明显增长态势,案件跟风示范效应明显,高附加值产品逐渐成为重点调查对象,运用反倾销手段遏制中国医药企业竞争优势已经成为惯用手法。医药贸易摩擦的应对需要发挥"四体联动"机制的积极作用,同时积极推进我国医药产业转型升级和国际化发展。With international industries competition getting fiercer in 2017,the trade frictions encountered by China's pharmaceutical trade increased significantly,the number counted as many as 15.The number of investigations initiated by emerging pharmaceutical markets had a significant increase and many countries followed the suit.High-value-added products gradually became the focus of investigations.And using anti-dumping measures to curb the competitive advantages of Chinese pharmaceutical companies has become the dominant method.The response to the pharmaceutical trade frictions needs the active role of the"four-subject synchronization"mechanism as well as the upgrading and internationalization of the pharmaceutical industry in China.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222